Twelve percent of US adults have now tried a GLP-1 medication, six percent are actively on one, and analysts project the active user base in North America will reach roughly thirty million by 2030. Canadian adoption sits about twenty percent higher per capita than the United States, which means Canadian operators are seeing the downstream effects earlier and harder than their American peers. Sixty-three percent of users report spending less at restaurants. Fifty percent report fewer restaurant visits overall. That is not a marketing dip or a recession blip. It is a structural shift in how a growing slice of the population buys food away from home.

The signal reached the main stage of the National Restaurant Association Show in 2026 with a panel titled The GLP-1 Effect, and Gordon Food Service Canada named Nutrient-Dense Shift the number one trend operators should plan for this year. These are not fringe indicators.

Tier 1: Ready-to-serve protein drinks. Boost High Protein delivers a consistent protein dose in a zero-labour format that holds well on a beverage cart or in a resident fridge. Tier 2: Bulk protein powders. Whey, plant-based blends, and casein let kitchens fortify soups, baked goods, oatmeal, pancakes, and beverages without changing the underlying recipe. Tier 3: Medical nutrition SKUs — fortified puddings, protein-enriched sides, and prepared entrees designed around nutrient density. Most LTC and hospital facilities need all three.

Restaurants in urban centres see customers who order differently — smaller mains, more appetizers, more protein-forward choices. Per-cover revenue from this segment is up even on lower covers because per-item spend rises. Hotels and short-term rentals that stock breakfast stations with high-protein options and minibars with protein snacks see direct guest satisfaction gains. Build-a-bowl formats and snack-style grazing menus map cleanly onto this need.